Article
Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung Cancer.
JAMA oncology - 1 Feb 2023
Lee Kirsty W C, Li Molly S C, Gai Wanxia, Lau Yat Ming, Chan Allen K C, Chan Oscar S H, Lee Chee Khoon, Yeung Rebecca M W, Fung Sherwood Y H, Cheung Wai F, Chan Vivian W, Leung Linda, Kam Kenny N P, Mok Tony S K
Abstract excerpt
Importance: Molecular testing in non-small cell lung cancer (NSCLC) is commonly limited by inadequate tumor sample. Plasma cell-free DNA (cfDNA) genotyping as a complementary test is specific but only moderately sensitive. Genotyping of cfDNA in pleural and pericardial effusion (PE-cfDNA) can further optimize molecular diagnostic yield and reduce the need for repeated biopsies. Objective: To prospectively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
